Homology Medicines, Inc. (FIXX) has a consensus analyst rating of Buy, based on 9 analysts covering the stock. Of those, 5 recommend buying, 4 recommend holding, and 0 recommend selling.
The analyst consensus price target for FIXX is $2.70, representing a +188.9% upside from the current price of $0.9347. Price targets range from a low of $2.70 to a high of $2.70.
